This page is in an archival section of the web site; the information may be outdated.
For current content, please visit UCSF Today at http://www.ucsf.edu/today/

UCSF logo

ArchivesCalendarCampus NotesCampus EyeLife StyleQuickLinksHelp ResourcesSearch

Daybreak home

Today's
Headlines

This Week's
News

Daybreak News Story
     

1st appeared 14 April 1999

Combining Exercise with Male Hormone Therapy Benefits Men with HIV-Wasting Disease

Men who suffer from HIV-wasting syndrome can benefit significantly from a combination of exercise and regular, moderate doses of male hormones, according to a new clinical study led by a UCSF researcher.

The study team found that the combined therapy produced an increase in lean-body mass and muscle strength, regardless of whether a patient was undergoing treatment with HIV anti-retroviral drugs known as protease inhibitors.

"This is an important point because weight gain after initiation of protease inhibitor therapy usually takes place through the accumulation of body fat, but our goal in patients with HIV-related weight loss is to build up the lean tissue," said lead study investigator Marc Hellerstein, UCSF associate professor of medicine, who treats patients at San Francisco General Hospital Medical Center.

The other key finding is that only a small amount of male hormones -- or androgens -- was necessary to produce positive results. "Much larger doses of androgens are often used by body-builders to develop muscular tissues, but such amounts have unproven long-term safety," said Hellerstein, who also is an associate professor of nutritional sciences at UC Berkeley.

Research results are reported in the current issue (April 14) of the Journal of the American Medical Association.

Links:

HIVInsite

San Francisco General Hospital Medical Center

Journal of the American Medical Association

Source: Corinna Kaarlela, News Services


DAYBREAK | ARCHIVES | CALENDAR | CAMPUS NOTES
CAMPUS EYE | LIFESTYLE | QUICK LINKS | HELP/RESOURCES | SEARCH

Copyright ©1999 Regents of the University of California. All rights reserved.
Last Updated May 11, 1999.
Please direct all comments and questions to the Daybreak Editor .
Please contact the UCSF Web Developer for questions of a technical nature.

New contact address: today@pubaff.ucsf.edu